Regulus Therapeutics Reports Fourth Quarter and Year-End 202

/PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines...

Related Keywords

San Diego , California , United States , Mohammad Ahmadian , Jay Hagan , Company Collaboration , Rnas The Company Or Regulus , Regulus Therapeutics Inc , Drug Administration , Nasdaq , Exchange Commission , Development Rd Expenses , Enterprise Associates , Kinovate Life Sciences Inc , Program Updates , Alport Syndrome , License Agreement , Private Placement , Federated Hermes Kaufmann Funds , New Enterprise Associates , Common Stock , Vice President , President Director , Kinovate Life Sciences , Webcast Information , Private Securities Litigation Reform Act ,